Research & Literature

Pemphigus herpetiformis: a case series and review of the literature.

Laws PM, Heelan K, Al-Mohammedi F, et al.

International journal of dermatology 2015; (54(9)):1014-22 doi:10.1111/ijd.12582.

Anti-desmocollin autoantibodies in nonclassical pemphigus.

Ishii N, Teye K, Fukuda S, et al.

The British journal of dermatology 2015; (173(1)):59-68 doi:10.1111/bjd.13711.

Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus.

Boulard C, Duvert Lehembre S, Picard-Dahan C, et al.

The British journal of dermatology 2016; (175(1)):142-9 doi:10.1111/bjd.14405.

A Case of Pemphigus Herpetiformis with Only Immunoglobulin G Anti-Desmocollin 3 Antibodies.

Hong WJ, Hashimoto T, Kim SC

Annals of dermatology 2016; (28(1)):102-6 doi:10.5021/ad.2016.28.1.102.

Assessment of the Effects of Rituximab Monotherapy on Different Subsets of Circulating T-Regulatory Cells and Clinical Disease Severity in Severe Pemphigus Vulgaris.

Bhattacharjee R, De D, Handa S, et al.

Dermatology (Basel, Switzerland) 2016; (232(5)):572-577 doi:10.1159/000448031.

A study of clinical, histopathological and direct immunofluorescence diagnosis in pemphigus group Utility of direct immunofluorescence.

Hrabovska Z, Jautova J, Hrabovsky V

Bratislavske lekarske listy 2017; (118(4)):243-249 doi:10.4149/BLL_2017_048.

Correlation between IL36α and IL17 and Activity of the Disease in Selected Autoimmune Blistering Diseases.

Żebrowska A, Woźniacka A, Juczyńska K, et al.

Mediators of inflammation 2017; (2017()):8980534 doi:10.1155/2017/8980534.

Sixteen-year history of rituximab therapy for 1085 pemphigus vulgaris patients: A systematic review.

Tavakolpour S, Mahmoudi H, Balighi K, et al.

International immunopharmacology 2018; (54()):131-138 doi:10.1016/j.intimp.2017.11.005.

Pemphigus herpetiformis - a case report of a rare form of pemphigus and review of the literature.

Stojković-Filipović J, Lekić B, Milčić D, Milinković MV

Vojnosanitetski pregled 2016; (73(10)):967-72 doi:10.2298/VSP150617044S.

Pemphigus herpetiformis in South Tunisia: a clinical expression of pemphigus foliaceus?

Jerbi A, Hachicha H, Feki S, et al.

International journal of dermatology 2018; (57(9)):1094-1101 doi:10.1111/ijd.14139.

Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.

Hébert V, Boulard C, Houivet E, et al.

The Journal of investigative dermatology 2019; (139(1)):31-37 doi:10.1016/j.jid.2018.04.042.

Bullous autoimmune dermatoses.

Hofmann SC, Juratli HA, Eming R

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2018; (16(11)):1339-1358 doi:10.1111/ddg.13688.

Rituximab therapy for refractory autoimmune bullous diseases: A multicenter, open-label, single-arm, phase 1/2 study on 10 Japanese patients.

Kurihara Y, Yamagami J, Funakoshi T, et al.

The Journal of dermatology 2019; (46(2)):124-130 doi:10.1111/1346-8138.14732.

Clinical, pathologic, and immunologic features of pemphigus herpetiformis: a literature review and proposed diagnostic criteria.

Costa LMC, Cappel MA, Keeling JH

International journal of dermatology 2019; (58(9)):997-1007 doi:10.1111/ijd.14395.

MPGN Type 3 Associated with Pemphigus Herpetiformis Mimicking PGNMID and Dermatitis Herpetiformis.

Shimizu Y, Wakabayashi K, Hayashi Y, et al.

Case reports in nephrology and dialysis 2019; (9(1)):15-24 doi:10.1159/000498939.

Development of a Desmocollin-3 Active Mouse Model Recapitulating Human Atypical Pemphigus.

Lotti R, Atene CG, Marconi A, et al.

Frontiers in immunology 2019; (10()):1387 doi:10.3389/fimmu.2019.01387.

Assessing the Correlation Between Disease Severity Indices and Quality of Life Measurement Tools in Pemphigus.

Krain RL, Kushner CJ, Tarazi M, et al.

Frontiers in immunology 2019; (10()):2571 doi:10.3389/fimmu.2019.02571.

Increased expression of in situ IL-31RA and circulating CXCL8 and CCL2 in pemphigus herpetiformis suggests participation of the IL-31 family in the pathogenesis of the disease.

Morais KL, Miyamoto D, Orfali RL, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2020; (34(12)):2890-2897 doi:10.1111/jdv.16730.

Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV).

Joly P, Horvath B, Patsatsi Α, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2020; (34(9)):1900-1913 doi:10.1111/jdv.16752.

Features and associated factors of bacterial skin infections in hospitalized patients with pemphigus: a single-center retrospective study.

Li F, Wu Y, Bian W, et al.

Annals of clinical microbiology and antimicrobials 2020; (19(1)):46 doi:10.1186/s12941-020-00388-6.

Atypical pemphigus: autoimmunity against desmocollins and other non-desmoglein autoantigens.

Gualtieri B, Marzano V, Grando SA

Italian journal of dermatology and venereology 2021; (156(2)):134-141 doi:10.23736/S2784-8671.20.06619-5.

A retrospective analysis of pemphigus vulgaris patients: Demographics, diagnosis, co-morbid diseases and treatment modalities used.

Askin O, Ozkoca D, Kutlubay Z, Mat MC

Northern clinics of Istanbul 2020; (7(6)):597-602 doi:10.14744/nci.2020.37039.

Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.

Werth VP, Joly P, Mimouni D, et al.

The New England journal of medicine 2021; (384(24)):2295-2305 doi:10.1056/NEJMoa2028564.

A case of pemphigus herpetiformis with excellent response to mycophenolate mofetil.

Sánchez-Pérez AP, Urbina-Calderón F, Pretell-Vera J, et al.

Acta dermatovenerologica Alpina, Pannonica, et Adriatica 2021; (30(2)):87-88.

Comparison of Guidelines for Management of Pemphigus: a Review of Systemic Corticosteroids, Rituximab, and Other Immunosuppressive Therapies.

Zhao W, Wang J, Zhu H, Pan M

Clinical reviews in allergy & immunology 2021; (61(3)):351-362 doi:10.1007/s12016-021-08882-1.

Comprehensive review on the pathophysiology, clinical variants and management of pemphigus (Review).

Costan VV, Popa C, Hâncu MF, et al.

Experimental and therapeutic medicine 2021; (22(5)):1335 doi:10.3892/etm.2021.10770.

Clinical severity scores as a guide for prediction of initial treatment responses in pemphigus and pemphigoid patients.

Tanaka R, Kurihara Y, Egami S, et al.

The Journal of dermatology 2023; (50(2)):203-211 doi:10.1111/1346-8138.16532.

Linear Immunoglobulin A (IgA) Bullous Dermatosis Mimicking Stevens-Johnson Syndrome.

Park JS, Hamilton CD, Patel S, et al.

Cureus 2022; (14(10)):e30309 doi:10.7759/cureus.30309.

The human skin organ culture model as an optimal complementary tool for murine pemphigus models.

Hartmann V, Hariton WV, Rahimi S, et al.

Laboratory animals 2023; (57(4)):381-395 doi:10.1177/00236772221145647.

A case of herpetiform pemphigus mimicking bullous pemphigoid after using secukinumab and successfully treated with sulfasalazine.

Wang R, Wang M

The Journal of dermatology 2023; (50(12)):1625-1628 doi:10.1111/1346-8138.16936.

Retrospective analysis of autoimmune bullous diseases in Middle Franconia.

Sollfrank L, Schönfelder V, Sticherling M

Frontiers in immunology 2023; (14()):1256617 doi:10.3389/fimmu.2023.1256617.

State-of-the-art diagnosis of autoimmune blistering diseases.

van Beek N, Holtsche MM, Atefi I, et al.

Frontiers in immunology 2024; (15()):1363032 doi:10.3389/fimmu.2024.1363032.

Autoimmune pemphigus: difficulties in diagnosis and the molecular mechanisms underlying the disease.

Simionescu O, Tudorache SI

Frontiers in immunology 2025; (16()):1481093 doi:10.3389/fimmu.2025.1481093.

Pemphigus herpetiformis: a single-center tertiary care experience.

Erkayman MH, Bilen H, Karaca Ural Z, Demirci E

Turkish journal of medical sciences 2025; (55(3)):719-726 doi:10.55730/1300-0144.6020.

A Case Report of Wolf's Post-Herpetic Isotopic Response: Herpetiform Pemphigus.

Tang S, Wang L, Liu Y, et al.

Journal of inflammation research 2025; (18()):9275-9282 doi:10.2147/JIR.S522003.

VARIANT_P: a 14-years multicentric follow-up study of atypical pemphigus variants in Italy.

Quintarelli L, Bonanni I, Mariotti EB, et al.

Clinical and experimental dermatology 2025; doi:10.1093/ced/llaf438.

Introducing human 3D skin models as a new serological diagnostic tool for severe autoimmune bullous diseases.

Huth L, Heise R, Marquardt Y, et al.

Frontiers in immunology 2025; (16()):1661851 doi:10.3389/fimmu.2025.1661851.

Emerging Treatments in Pemphigus: Is Healing an Achievable Goal?

Horváth B, Hiel MAJ, Strandmoe AL, Meijer JM

American journal of clinical dermatology 2026; (27(2)):317-327 doi:10.1007/s40257-025-01002-1.

Pemphigus Herpetiformis Presenting With Mucosal Involvement: A Rare Clinical Presentation.

Mayouf H, Alkandari D, Hussin M, Alajmi FM

Cureus 2026; (18(4)):e106446 doi:10.7759/cureus.106446.

Impact of Poor Adherence to Treatment on Recurrent Disease Activity in Pemphigus Foliaceus: A Case Report.

Vazquez Enriquez LF, Dominguez Romo K, Hurtado Cordova JM

Cureus 2026; (18(5)):e109929 doi:10.7759/cureus.109929.

A Case of Pemphigus Herpetiformis in a 10-Year-Old Child.

Hao Z, Fan L, Song H, Xiang Z

Clinical, cosmetic and investigational dermatology 2026; (19()):605164 doi:10.2147/CCID.S605164.